Eastman Chemical EMN
Eastman Chemical reported $2.38 billion in revenue for Q3 2026.
- Form
- 10-Q
- Filed
- Importance
- Notable
- Accession
- 0000915389-26-000172
- Revenue: $2.38 billion for the three months ended Sep 30, 2026
- Net income: $252 million for the three months ended Sep 30, 2026
- Diluted EPS: $2.19 for the three months ended Sep 30, 2026
- Cash and equivalents: $768 million at Sep 30, 2026
Written from the 10-Q on EDGAR. Check the filing before you rely on it.
What changed
5 changes since the June 2026 10-Q
Compared with the 10-Q 0000915389-26-000141, filed Jul 31, 2026.
New legal mention
There have been no material changes to the legal proceedings previously disclosed in Part I, Item 3 of the Company's 2025 Annual Report on Form 10-K .
From the filings
Now
There have been no material changes to the legal proceedings previously disclosed in Part I, Item 3 of the Company's 2025 Annual Report on Form 10-K .Net income up 38% from Jun 30
$252M, was $183M.
From the filings
Before
$183MNow
$252MEPS up 38% from Jun 30
$2.19, was $1.59.
From the filings
Before
$1.59Now
$2.19Cash up 11% from Jun 30
$768M, was $691M.
From the filings
Before
$691MNow
$768MRevenue down 5.1% from Jun 30
$2.4B, was $2.5B.
From the filings
Before
$2.5BNow
$2.4B
Show the redline
Section by section. Added words and removed words against the earlier filing.
Cover page 3 changes
3 unchanged paragraphs
For the quarterly period ended June September 30, 2026
21 unchanged paragraphs
Class Number of Shares Outstanding at June September 30, 2026
Common Stock, par value $0.01 per share 114,377,421 114,380,456
Forward-looking statements 1 change
Certain statements made or incorporated by reference in this Quarterly Report are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act (Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Forward-looking statements are all statements, other than statements of historical fact, that may be made by Eastman Chemical Company ("Eastman" or the "Company") from time to time. In some cases, you can identify forward-looking statements by terminology such as "anticipates", "believes", "estimates", "expects", "intends", "may", "plans", "projects", "forecasts", "will", "would", "could", and similar expressions, or expressions of the negative of these terms. Forward-looking statements may relate to, among other things, such matters as planned and expected capacity increases and utilization; anticipated capital spending; expected depreciation and amortization; environmental matters and opportunities (including potential risks associated with physical and transitional impacts of climate change and related voluntary and regulatory carbon requirements); exposure to and effects of hedging raw material and energy prices and costs and foreign currencies exchange and interest rates; disruption or interruption of operations and of raw material or energy supply (including as a result of cyber-attacks or other breaches of the Company's information security systems); global and regional economic, political, and business conditions, including heightened inflation, capital market volatility, interest rate and currency fluctuations, and economic slowdown or recession; impacts from U.S. tariffs, reciprocal tariffs, and global trade disruption, including impacts from the conflict in the Middle East; competition; growth opportunities; supply and demand, volume, price, cost, margin, and sales; pending and future legal proceedings; earnings, cash flow, dividends, stock repurchases, and other expected financial results, events, decisions, and conditions; expectations, strategies, and plans for individual assets and products, businesses, and operating segments, as well as for the whole of Eastman; cash sources and requirements and uses of available cash; financing plans and activities; pension expenses and funding; a weakening of global credit markets or changes to our credit ratings; anticipated and other future restructuring, acquisition, divestiture, and consolidation activities; cost reduction and control efforts and targets; the timing and costs of, benefits from the integration of, and expected business and financial performance of acquired businesses, as well as the subsequent impairment assessments of acquired long-lived assets; strategic, technology, and product innovation initiatives and development, production, commercialization, and acceptance of new products, services, and technologies and related costs; asset, business, and product portfolio changes; and expected tax rates and interest costs.
3 unchanged paragraphs
Financial statements 47 changes
2 unchanged paragraphs
Second Quarter First Six Months
Third Quarter First Nine Months
1 unchanged paragraph
Sales $ 2,513 $ 2,287 $ 4,690 $ 4,577
Cost of sales 1,953 1,781 3,699 3,504
Gross profit 560 506 991 1,073
Research and development expenses 65 67 125 134
Sales $ 2,385 $ 2,202 $ 7,075 $ 6,779
Cost of sales 1,853 1,769 5,552 5,273
Gross profit 532 433 1,523 1,506
Selling, general, and administrative expenses 185 157 363 339 171 160 534 499
Research and development expenses 63 63 188 197
1 unchanged paragraph
Other (income) charges, net 14 49 27 57
Net interest expense 55 53 107 102
Earnings before income taxes 256 169 392 422
Net earnings 184 140 291 323
Basic earnings per share attributable to Eastman $ 1.60 $ 1.22 $ 2.54 $ 2.80
Diluted earnings per share attributable to Eastman $ 1.59 $ 1.20 $ 2.51 $ 2.77
Other components of post-employment (benefit) cost, net ( 16 17 ) ( 2 1 ) ( 33 50 ) ( 3 4 )
Other (income) charges, net 10 3 37 60
Earnings before interest and taxes 311 222 499 524 305 188 804 712
Net interest expense 56 54 163 156
Earnings before income taxes 249 134 641 556
(Benefit from) provision for income taxes ( 4 ) 65 97 164
Net earnings 253 69 544 392
Less: Net earnings attributable to noncontrolling interest 1 1 2 1
Net earnings attributable to Eastman $ 183 252 $ 140 69 $ 290 542 $ 322 391
Basic earnings per share attributable to Eastman $ 2.21 $ 0.60 $ 4.75 $ 3.41
Diluted earnings per share attributable to Eastman $ 2.19 $ 0.60 $ 4.70 $ 3.38
1 unchanged paragraph
Net earnings including noncontrolling interest $ 184 253 $ 140 69 $ 291 544 $ 323 392
1 unchanged paragraph
Change in cumulative translation adjustment ( 13 ) ( 6 ) ( 4 ) 2 15 15 11 17
1 unchanged paragraph
Amortization of unrecognized prior service credits included in net periodic costs ( 8 7 ) ( 15 22 )
1 unchanged paragraph
Unrealized gain (loss) during period 2 ( 32 3 ) 18 1 15 ( 45 44 )
Reclassification adjustment for (gains) losses included in net income, net 3 6 1 4 10
Total other comprehensive income (loss), net of tax ( 19 ) ( 32 ) 8 22 8 ( 39 17 )
Comprehensive income including noncontrolling interest 165 108 291 284 261 91 552 375
Less: Comprehensive income attributable to noncontrolling interest 1 1 2 1
Comprehensive income attributable to Eastman $ 164 260 $ 108 91 $ 290 550 $ 283 374
1 unchanged paragraph
UNAUDITED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
UNAUDITED CONSOLIDATED BALANCE SHEETS
June September 30, December 31,
1 unchanged paragraph
Miscellaneous receivables 268 262
Cash and cash equivalents $ 691 768 $ 566
Trade receivables, net of allowance for credit losses 1,097 1,062 737
Miscellaneous receivables 262 262
Inventories 2,101 2,186 1,980
Other current assets 98 87 100
Total current assets 4,255 4,365 3,645
Properties 317 changes
Properties and equipment at cost 14,642 14,707 14,507
Less: Accumulated depreciation 8,956 9,061 8,776
Net properties 5,686 5,646 5,731
Goodwill 3,661 3,662 3,665
Intangible assets, net of accumulated amortization 924 905 970
Other noncurrent assets 898 888 848
Total assets $ 15,424 15,466 $ 14,859
1 unchanged paragraph
Payables and other current liabilities $ 2,075 2,008 $ 2,066
Borrowings due within one year 765 764 586
Total current liabilities 2,840 2,772 2,652
Long-term borrowings 4,452 4,454 4,201
Deferred income tax liabilities 685 740 669
Post-employment obligations 393 383 409
Other long-term liabilities 879 782 891
Total liabilities 9,249 9,131 8,822
1 unchanged paragraph
Noncontrolling interest 79 76
Common stock ($ 0.01 par value 350,000,000 shares authorized; shares issued 224,218,154 224,221,189 and 223,938,047 as of June September 30, 2026 and December 31, 2025)
Additional paid-in capital 2,539 2,555 2,500
Retained earnings 10,201 10,357 10,105
Accumulated other comprehensive income (loss) ( 160 152 ) ( 160 )
Less: Treasury stock at cost ( 109,891,531 and 109,891,531 shares as of June September 30, 2026 and December 31, 2025)
Total Eastman stockholders' equity 6,096 6,276 5,961
Noncontrolling interest 59 76
Total equity 6,175 6,335 6,037
Total liabilities and stockholders' equity $ 15,424 15,466 $ 14,859
4 unchanged paragraphs
Net earnings $ 291 $ 323
Net earnings $ 544 $ 392
1 unchanged paragraph
Provision (benefit) from deferred income taxes 10 ( 48 )
Depreciation and amortization 263 253 397 382
Provision for deferred income taxes 65 39
1 unchanged paragraph
(Increase) decrease in trade receivables ( 369 332 ) ( 183 131 )
(Increase) decrease in inventories ( 146 ) ( 131 229 ) 73
Increase (decrease) in trade payables 85 ( 155 275 )
Pension and other postretirement contributions (in excess of) less than expenses ( 48 67 ) ( 17 28 )
Variable compensation payments (in excess of) less than expenses 22 77 ( 86 60 )
Other items, net ( 21 78 ) 110 76
Net cash provided by operating activities 87 66 377 468
1 unchanged paragraph
Additions to properties and equipment ( 203 298 ) ( 297 434 )
1 unchanged paragraph
Other items, net ( 3 4 ) 5
5 unchanged paragraphs
Dividends paid to stockholders ( 192 288 ) ( 191 287 )
Treasury stock purchases ( 50 100 )
1 unchanged paragraph
Effect of exchange rate changes on cash and cash equivalents 12 14
Net change in cash and cash equivalents 125 202 ( 414 348 )
1 unchanged paragraph
Cash and cash equivalents at end of period $ 691 768 $ 423 489
12 unchanged paragraphs
The accompanying unaudited consolidated financial statements have been prepared by Eastman Chemical Company ("Eastman" or the "Company") in accordance and consistent with the accounting policies stated in the Company's 2025 Annual Report on Form 10-K , and should be read in conjunction with the consolidated financial statements in Part II, Item 8 of that report, with the exception of recently adopted accounting standards and policy elections noted below. The December 31, 2025 financial position data included herein was derived from the consolidated financial statements included in the 2025 Annual Report on Form 10-K but does not include all disclosures required by accounting principles generally accepted in the United States ("GAAP").
In the opinion of management, the unaudited consolidated financial statements include all normal recurring adjustments necessary for the fair presentation of the interim financial information in conformity with GAAP. These statements contain some amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates and judgments. The unaudited consolidated financial statements include assets, liabilities, sales revenue, and expenses of all majority-owned subsidiaries and joint ventures in which a controlling interest is maintained. Eastman accounts for other joint ventures and investments in minority-owned companies where it exercises significant influence on an under the equity basis. method. Intercompany transactions and balances are eliminated in consolidation.
2 unchanged paragraphs
Accounting Standards Issued But Not Adopted as of June September 30, 2026
6 unchanged paragraphs
Confirmed obligations in these programs of $ 138 million and $ 110 million at June 30, 2026 and December 31, 2025 are included in "Payables and other current liabilities" on the Unaudited Consolidated Statements of Financial Position.
The Company engages in off-balance sheet, uncommitted accounts receivable factoring programs as a routine part of its ordinary business operations. Through these programs, entire invoices may be sold to third-party financial institutions, the vast majority of which are without recourse. Under these agreements, the Company sells the invoices at face value, less a transaction fee, which substantially equals the carrying value and fair value with no gain or loss recognized, and no credit loss exposure is retained. Available capacity under these programs, which the Company uses as a routine source of working capital funding, is dependent on the level of accounts receivable eligible to be sold and the financial institutions' willingness to purchase such receivables. In addition, certain programs also require that the Company continue to service, administer, and collect the sold accounts receivable at market rates. The total amounts sold under the program in second third quarter 2026 and 2025 were $ 657 647 million and $ 674 696 million and in both first six nine months 2026 and 2025 were $ 1.3 billion and $ 1.4 2.0 billion.
The Company works with suppliers to optimize payment terms and conditions on accounts payable to enhance the timing of working capital and cash flows. As part of its supplier financing programs, suppliers may voluntarily sell receivables due from Eastman to a participating financial institution. Eastman's responsibility is limited to making payments on the terms originally negotiated with suppliers, and the range of payment terms Eastman negotiates with suppliers is consistent regardless of whether a supplier participates in the program. Either Eastman or a participating financial institution may terminate a supplier finance program upon 90 days' notice. Within these programs, the Company maintains a structured payables program that utilizes a payables processing arrangement with a financial institution to support the processing and settlement of freight and logistics invoices, whereby the financial institution remits payments to certain freight service providers based on invoices approved by the Company, and the Company reimburses the financial institution. The Company pays fixed per transaction fees for the invoice processing and payment services for the structured payables program. Confirmed obligations in these programs of $ 135 million and $ 110 million at September 30, 2026 and December 31, 2025 are included in "Payables and other current liabilities" on the Unaudited Consolidated Balance Sheets.
On May 29, 2025, the U.S. Department of Energy ("DOE") terminated an award related to the Company's Polyethylene Terephthalate Recycling Decarbonization Project in Longview, Texas. The Company received $ 3 million in reimbursements from the DOE during first quarter 2026 related to reimbursement requests from the prior year. All requested reimbursements were received as of March 31, 2026. The Company has subsequently submitted an agency appeal seeking reinstatement of the award, which was reinstated in October 2026.
3 unchanged paragraphs
Eastman recognizes the financial statement effects of changes in laws or regulations in the period in which the Company obtains a legal right to the related asset or incurs a legal obligation for the related liability. On February 20, 2026, the Supreme Court ruled that the tariffs imposed under the International Emergency Economic Powers Act ("IEEPA") were not sufficiently authorized and deemed invalid. Further, on March 4, 2026, the Court of International Trade ruled that U.S. Customs and Border Protection must refund IEEPA tariffs that were collected. As a result of these court rulings establishing the Company's legal right to a refund of IEEPA tariffs, the Company recognized a $ 2 million and $ 24 million benefit in "Cost of sales" in the Unaudited Consolidated Statements of Earnings and Comprehensive Income in the second quarter and first six months 2026. In second quarter 2026, the Company received $ 22 million in tariff refunds in the first nine months 2026. As of June September 30, 2026, $ 2 million was reflected as "Miscellaneous receivables" on the Unaudited Consolidated Statements of Financial Position Balance Sheets related to IEEPA tariff refunds.
Revision of Previously Issued Financial Statements
The Company identified an error in the previously issued third quarter 2025 financial statements related to the newly enacted One Big Beautiful Bill Act ("OBBBA") that impacted the provision for income tax. The revision did not affect the previously reported annual financial statements included in the Company's 2025 Annual Report on Form 10-K . The Company evaluated the impact of this item under the guidance of the Securities and Exchange Commission's Staff Accounting Bulletin No. 99, "Materiality," and determined that this error was not material to its previously issued financial statements. However, the Company revised the previously issued financial statements to correct the error. The impact of this revision to "Provision for income taxes" and "Payables and other current liabilities" increased net earnings by $ 22 million and decreased total current liabilities by $ 22 million as compared to what was previously reported. The revision also increased basic and diluted earnings per share by $ 0.19 and $ 0.20 for three months ended September 30, 2025, and both basic and diluted earnings per share by $ 0.20 for nine months ended September 30, 2025. The footnotes have also been updated.
June September 30, December 31,
1 unchanged paragraph
Second Quarter First Six Months
Finished goods $ 1,356 1,471 $ 1,361
Work in process 332 322 300
Raw materials and supplies 741 716 657
Total inventories at FIFO or average cost 2,429 2,509 2,318
Less: LIFO reserve 328 323 338
Total inventories $ 2,101 2,186 $ 1,980
Inventories valued on the last-in, first-out ("LIFO") method were approximately 55 percent of total inventories at both June September 30, 2026 and December 31, 2025.
Third Quarter First Nine Months
1 unchanged paragraph
Second quarter and first six months 2026 provision for income taxes included the impact of transitional provisions of the One Big Beautiful Bill Act primarily related to the deductibility of previously capitalized research and development expenditures. Second quarter and first six months 2025 provision for income taxes included an increase related to uncertain tax positions offset by a decrease related to the foreign rate variance due to the Company's mix of earnings.
(Benefit from) provision for income taxes and tax rate $ ( 4 ) ( 2 ) % $ 65 49 % $ 97 15 % $ 164 30 %
Third quarter and first nine months 2026 (benefit from) provision for income taxes included a $61 million reduction in unrecognized tax benefits, inclusive of related interest, based on the evaluation of new external information arising during third quarter 2026. Additionally, third quarter and first nine months 2026 included the impact of transitional provisions of the OBBBA primarily related to the deductibility of previously capitalized research and development expenditures. Third quarter and first nine months 2025 provision for income taxes included an increase of $22 million driven by OBBBA. First nine months 2025 provision for income taxes also included an increase of $35 million related to unrecognized tax benefits.
At June September 30, 2026 and December 31, 2025, Eastman had $ 185 132 million and $ 183 million in unrecognized tax benefits.
1 unchanged paragraph
June September 30, December 31,
11 unchanged paragraphs
Total borrowings 5,217 5,218 4,787
Less: Borrowings due within one year 765 764 586
Long-term borrowings $ 4,452 4,454 $ 4,201
3 unchanged paragraphs
The Company has access to a $ 1.50 billion revolving credit agreement (the "Credit Facility") that matures in February 2031. Borrowings under the Credit Facility are subject to interest at varying spreads above quoted market rates and a commitment fee is paid on the total unused commitment. The Credit Facility provides available liquidity for general corporate purposes and supports commercial paper borrowings. Commercial paper borrowings are classified as short-term. In February 2026, the Credit Facility was amended to extend the maturity to February 2031 and to temporarily adjust the maximum leverage ratio covenant through fiscal quarter ending June 30, 2027 in the event of further macroeconomic uncertainty impacting operating results. All other material terms of the Credit Facility remained unchanged. At June September 30, 2026 and December 31, 2025, the Company had no outstanding borrowings under the Credit Facility and no commercial paper borrowings.
1 unchanged paragraph
The Credit Facility contains customary covenants, including requirements to maintain certain financial ratios, that determine the events of default, amounts available, and terms of borrowings. The Company was in compliance with all applicable covenants at both June September 30, 2026 and December 31, 2025.
2 unchanged paragraphs
Eastman has classified its total borrowings at June September 30, 2026 and December 31, 2025 under the fair value hierarchy as defined in the accounting policies in Note 1, "Significant Accounting Policies", to the consolidated financial statements in Part II, Item 8 of the Company's 2025 Annual Report on Form 10-K . The fair value for fixed-rate debt securities is based on quoted market prices for the same or similar debt instruments and is classified as Level 2. The fair value of the Company's other borrowings equals the carrying value and is classified as Level 2. The Company's fair value of total borrowings was $ 5.1 4.9 billion at June September 30, 2026 and $ 4.7 billion at December 31, 2025. The Company had no borrowings classified as Level 1 or Level 3 as of June September 30, 2026 and December 31, 2025.
4 unchanged paragraphs
Cash flow hedges are derivative instruments designated as and used to hedge the exposure to variability in expected future cash flows that are attributable to a particular risk. The derivative instruments that are designated and qualify as a cash flow hedge are reported on the balance sheet at fair value, and the changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the anticipated cash flows of the underlying exposures being hedged. The change in the hedge instrument is reported as a component of "Accumulated other comprehensive income (loss)" ("AOCI") on the Unaudited Consolidated Statements of Financial Position Balance Sheets and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Cash flows from cash flow hedges are classified as operating activities in the Unaudited Consolidated Statements of Cash Flows.
Fair value hedges are defined as derivative or non-derivative instruments designated as and used to hedge the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk. The derivative instruments that are designated and qualify as fair value hedges are reported as "Short-term borrowings" or "Long-term borrowings" on the Unaudited Consolidated Statements of Financial Position Balance Sheets at fair value, and the changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the anticipated fair value of the underlying exposures being hedged. The net of the change in the hedge instrument and item being hedged for qualifying fair value hedges is recognized in earnings in the same period or periods during which the hedged transaction affects earnings. Cash flows from fair value hedges are classified as operating activities in the Unaudited Consolidated Statements of Cash Flows.
1 unchanged paragraph
Net investment hedges are defined as derivative or non-derivative instruments designated as and used to hedge the foreign currency exposure of the net investments in certain foreign operations. The net of the change in the hedge instrument and item being hedged for qualifying net investment hedges is reported as a component of the "Cumulative translation adjustment" ("CTA") within AOCI on the Unaudited Consolidated Statements of Financial Position. Balance Sheets. Cash flows from the CTA component are classified as operating activities in the Unaudited Consolidated Statements of Cash Flows. Recognition in earnings of amounts previously recognized in CTA is limited to circumstances such as complete or substantially complete liquidation of the net investment in the hedged foreign operation. In the event of a complete or substantially complete liquidation of the net investment, cash flows from net investment hedges are classified as investing activities in the Unaudited Consolidated Statements of Cash Flows.
1 unchanged paragraph
For derivative cross-currency interest rate swap net investment hedges, gains and losses representing hedge components excluded from the assessment of effectiveness are recognized in CTA within AOCI and recognized in earnings through the periodic swap interest accruals. The cross-currency interest rate swaps designated as net investment hedges are included as part of "Other long-term liabilities", "Other noncurrent assets", "Payables and other current liabilities", or "Other current assets" on the Unaudited Consolidated Statements of Financial Position. Balance Sheets. Cash flows from excluded components are classified as operating activities in the Unaudited Consolidated Statements of Cash Flows.
5 unchanged paragraphs
The following table presents the notional amounts outstanding at June September 30, 2026 and December 31, 2025 associated with Eastman's hedging programs.
2 unchanged paragraphs
1 unchanged paragraph
9 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
2 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
2 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
5 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
3 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
5 unchanged paragraphs
2 unchanged paragraphs
3 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
2 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
2 unchanged paragraphs
3 unchanged paragraphs
3 unchanged paragraphs
2 unchanged paragraphs
4 unchanged paragraphs
3 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
2 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
3 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
1 unchanged paragraph
2 unchanged paragraphs
3 unchanged paragraphs
1 unchanged paragraph
3 unchanged paragraphs
2 unchanged paragraphs
2 unchanged paragraphs
2 unchanged paragraphs
1 unchanged paragraph
3 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
3 unchanged paragraphs
1 unchanged paragraph
1 unchanged paragraph
7 unchanged paragraphs
2 unchanged paragraphs
5 unchanged paragraphs
1 unchanged paragraph
4 unchanged paragraphs
2 unchanged paragraphs
2 unchanged paragraphs
4 unchanged paragraphs
1 unchanged paragraph
and 237 more changes in the filing
Market risk 1 change
2 unchanged paragraphs
At June September 30, 2026, the market risk associated with certain cash flows under foreign currency derivative transactions assuming a 10 percent adverse move in the U.S. dollar relative to these foreign currencies was $33 $31 million, with an additional $3 million exposure for each additional one percentage point adverse change in those foreign currency rates. Since the Company utilizes currency-sensitive derivative instruments for hedging anticipated foreign currency transactions, a loss in fair value from those instruments is generally offset by an increase in the value of the underlying anticipated transactions.
1 unchanged paragraph
Controls and procedures 2 changes
1 unchanged paragraph
Eastman maintains a set of disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the Company's disclosure controls and procedures. Based on that evaluation, the CEO and CFO have concluded that as of June September 30, 2026, the Company's disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed was accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.
1 unchanged paragraph
There has been no change in the Company's internal control over financial reporting that occurred during second third quarter 2026 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.
Legal proceedings 3 changes
1 unchanged paragraph
Solutia Legacy Torts Claims Litigation
Pursuant to an Amended and Restated Settlement Agreement effective February 28, 2008 between Solutia, Inc. ("Solutia") and Monsanto Company ("Monsanto") in connection with Solutia's emergence from Chapter 11 bankruptcy proceedings (the "Monsanto Settlement Agreement"), Monsanto is responsible for the defense and indemnification of Solutia against any Legacy Tort Claims (as defined in the Monsanto Settlement Agreement) and Solutia has agreed to retain responsibility for certain tort claims, if any, that may arise from Solutia's conduct after its spinoff from Pharmacia Corporation (f/k/a Monsanto), which occurred on September 1, 1997. Solutia, which became a wholly-owned subsidiary of Eastman upon Eastman's acquisition of Solutia in July 2012, has been named as a defendant in several such proceedings, and has submitted the matters to Monsanto, which was acquired by Bayer AG in June 2018, as Legacy Tort Claims. To the extent these matters are not within the meaning of Legacy Tort Claims, Solutia could potentially be liable thereunder. In connection with the completion of its acquisition of Solutia, Eastman guaranteed the obligations of Solutia and Eastman was added as an indemnified party under the Monsanto Settlement Agreement.
There have been no material changes to the legal proceedings previously disclosed in Part I, Item 3 of the Company's 2025 Annual Report on Form 10-K .
Unregistered sales of stock 1 change
In December 2021, the Company's Board of Directors authorized the repurchase of up to $2.5 billion of the Company's outstanding common stock at such times, in such amounts, and on such terms, as determined by management to be in the best interest of the Company and its stockholders (the "2021 authorization"). As of June September 30, 2026, a total of 13,032,926 shares have been repurchased under the 2021 authorization for $1.2 billion. Both dividends and share repurchases are key strategies employed by the Company to return value to its stockholders. The Company did not repurchase shares of common stock during second third quarter or first six nine months 2026. For additional information, see Note 9, "Stockholders' Equity", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.
Exhibits 6 changes
2 unchanged paragraphs
3.02 Amended and Restated Bylaws of Eastman Chemical Company (incorporated herein by reference to Exhibit 3.2 3.1 to the Company's Current Report on Form 8-K dated December 1, 2022) October 20, 2026)
31.01 * Rule 13a 14(a) Certification by Mark J. Costa, Chief Executive Officer, for the quarter ended June September 30, 2026
31.02 * Rule 13a 14(a) Certification by William T. McLain, Jr., Executive Vice President and Chief Financial Officer, for the quarter ended June September 30, 2026
32.01 * Section 1350 Certification by Mark J. Costa, Chief Executive Officer, for the quarter ended June September 30, 2026
32.02 * Section 1350 Certification by William T. McLain, Jr., Executive Vice President and Chief Financial Officer, for the quarter ended June September 30, 2026
11 unchanged paragraphs
Date: July 31, October 30, 2026 By: /s/ William T. McLain, Jr.
2 unchanged paragraphs
Unchanged: MD&A, Risk factors, Other information
Compared by code from the two filings' text and XBRL. Not advice.
The reading, claim by claim
1 of 1 claim matched the filing text.
From the filing's financial data, not stated in its text
From this 10-Q's financial data (XBRL) for the quarter ended September 30, 2026
- For the quarter ended September 30, 2026, EASTMAN CHEMICAL CO reported: Revenue $2.4 billion.
- Gross margin 22.3%.
- Net margin 10.6%.
- Revenue change from a year earlier +8.3%.
From the filing
ITEM 1. FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS UNAUDITED CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
Third Quarter First Nine Months
Asset impairments, restructuring, and other charges, net
Comprehensive Income
Defined benefit pension and other postretirement benefit plans:
Amortization of unrecognized prior service credits included in net periodic costs
The accompanying notes are an integral part of these unaudited consolidated financial statements.
4
Ta
Similar companies
Companies of similar size in SIC 2821 and related industry codes: the same peer list as the financial tables.
- Albemarle ALB public float $7.4B, Jun 30, 2025
- Celanese CE public float $6.0B, Jun 30, 2025
- DuPont de Nemours DD public float $12.0B, Jun 30, 2025
- Sealed Air SEE public float $4.6B, Jun 30, 2025
- Hexcel HXL public float $4.5B, Jun 30, 2025
